MISOPROSTOL
Test Ligands Values Explained
- Test Ligand ID - A unique identifier for the test ligand
- Ligand Name - Name of the test ligand
Test Ligand ID | 1237 |
---|---|
Ligand Name | MISOPROSTOL |
PubMed Compound Id | 5282381 |
Structure | |
Molecular Formula | C22H38O5 |
Molecular Weight | 382.5 |
SMILES | CCCCC(C)(C/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)OC)O)O |
Synonyms | misoprostol 59122-46-2 Isprelor Misoprostolum Misoprost Misoprostil Misotol Misogon Misotac Misoprostolum [INN-Latin] CCRIS 6859 HSDB 3573 UNII-0E43V0BB57 BRN 4155643 DTXSID7020897 MVI 200 0E43V0BB57 misoprostol (methyl ester) DTXCID70897 Methyl (+-)-11-alpha,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate ARTHROTEC COMPONENT MISOPROSTOL Misoprostol [USAN:USP:INN:BAN:JAN] methyl (11alpha,13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate Misoprostolum (INN-Latin) MISOPROSTOL (MART.) MISOPROSTOL [MART.] MISOPROSTOL (USP-RS) MISOPROSTOL [USP-RS] MISOPROSTOL (EP MONOGRAPH) MISOPROSTOL [EP MONOGRAPH] MISOPROSTOL (USP MONOGRAPH) MISOPROSTOL [USP MONOGRAPH] Misoprostol (USAN:USP:INN:BAN:JAN) misoprostolo Misoprostol 1% Misoprostol 1% Dispersion CHEBI:63610 A02BB01 G02AD06 MISOPROSTOL COMPONENT OF ARTHROTEC Cytotec SC-29333 Misodel SC 29333 Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester,(11a,13E)- methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate 103601-27-0 NCGC00162445-02 rel-Methyl 7-((1R,2R,3R)-3-hydroxy-2-((E)-4-hydroxy-4-methyloct-1-en-1-yl)-5-oxocyclopentyl)heptanoate Misopess GyMiso 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoic acid methyl ester 848849-83-2 methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(1E)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate Cytotec (TN) SR-01000695425 Misoprostol, 1% in cellulose XP-16J Misoprostol HPMC CAS_59122-46-2 MISOPROSTOL [MI] MISOPROSTOL [INN] MISOPROSTOL [JAN] MISOPROSTOL [HSDB] MISOPROSTOL [USAN] CHEMBL606 MISOPROSTOL [VANDF] SCHEMBL7787 (11-alpha,13E)-(+-)-11,16-Dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid methyl ester MISOPROSTOL [WHO-DD] MLS000028863 Misoprostol (JAN/USP/INN) GTPL1936 Misoprostol - 1% in cellulose BDBM85606 CHEBI:94387 Misoprostol, >=99% (HPLC) MISOPROSTOL [ORANGE BOOK] REGID_for_CID_5282381 HMS2090L10 HMS3648F03 HMS3715K08 EX-A1774 HY-B0610 Tox21_112010 MFCD00274550 (+/-)-15-Deoxy-(16RS)-16-hydroxy-16-methylprostaglandin E1 methyl ester AKOS015899652 CCG-221093 DB00929 FM26017 FM46798 Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)- SMP1_000193 NCGC00162445-01 NCGC00162445-03 (+-)-Methyl (1R,2R,3R)-3-hydroxy-2-((E)-(4RS)-4-hydroxy-4-methyl-1-octenyl)-5-oxocyclopentaneheptanoate 1ST11389 AS-83017 methyl 7-((1R,2R,3R)-3-hydroxy-2-((E)-4-hydroxy-4-methyloct-1-en-1-yl)-5-oxocyclopentyl)heptanoate SMR000058558 CAS-59122-46-2 NS00005831 D00419 F88033 AB00513745-05 EN300-7483126 A832173 Q416025 SR-01000695425-2 SR-01000695425-4 BRD-A50310035-001-01-6 BRD-A72351335-001-04-5 Misoprostol, European Pharmacopoeia (EP) Reference Standard Misoprostol, United States Pharmacopeia (USP) Reference Standard (+/-) methyl 11alpha, 16-dihydroxy-16-methyl-9-oxoprost-13E-en-1-oate (+/-) methyl 11alpha,16-dihydroxy-16-methyl-9-oxoprost-13E-en-1-oate (+/-) methyl-11alpha,16-dihydroxy-16-methyl-9-oxoprost-13E-en-1-oate (+/-) methyl-11alpha,16-dihydroxy-16-methyl-9-oxoprost13E-en-1-oate (11a,13e)-(+/-)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid methyl ester Misoprostol for system suitability, European Pharmacopoeia (EP) Reference Standard (+/-)-METHYL (1R,2R,3R)-3-HYDROXY-2-((E)-(4RS)-4-HYDROXY-4-METHYL-1-OCTENYL)-5-OXOCYCLOPENTANEHEPTANOATE (11a,13E)-(+/-)-11,16-Dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid methyl ester;Cytotec;Misogon methyl 7-[(1R,2R,3R)-2-[(E)-4-methyl-4-oxidanyl-oct-1-enyl]-3-oxidanyl-5-oxidanylidene-cyclopentyl]heptanoate PROST-13-EN-1-OIC ACID, 11,16-DIHYDROXY-16-METHYL-9-OXO-, METHYL ESTER, (11.ALPHA.,13E)-(+/-)- Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)-(+-)- |
Created At | Jan 13, 2025 2:47 pm |
Updated At | Jan 13, 2025 2:47 pm |